Journal article
Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS2 and CHA2DS2-VASc Scores in Patients With Atrial Fibrillation
Abstract
BACKGROUND: The impact of apixaban versus aspirin on ischemic stroke and major bleeding in relation to the CHADS(2) and CHA(2)DS(2)-VASc stroke risk scores in atrial fibrillation has not been investigated.
METHODS AND RESULTS: In this secondary analysis of the AVERROES trial, our principal objective was to assess the effect of treatment with aspirin or apixaban on ischemic stroke and major bleeding, in relation to the CHADS(2)/CHA(2)DS(2)-VASc …
Authors
Lip GYH; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J
Journal
Circulation Arrhythmia and Electrophysiology, Vol. 6, No. 1, pp. 31–38
Publisher
Wolters Kluwer
Publication Date
February 2013
DOI
10.1161/circep.112.975847
ISSN
1941-3149